![]() After reaching the maximum annual Program benefit amount, the patient will be responsible for all remaining out-of-pocket expenses. It does not assist with the cost of other medicines, procedures or office visit fees. The Program assists with the cost of the Genentech medicine only. The total patient out-of-pocket cost is dependent on the patient’s health insurance plan. The final amount owed by a patient may be as little as $0 for the Genentech medicine (see Program specific details). Under the Program, the patient may pay a co-pay. The Program is not valid for Genentech medicines that are eligible to be reimbursed in their entirety by private insurance plans or other programs. Patients using Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DoD), TRICARE or any other federal or state government program (collectively, “Government Programs”) to pay for their Genentech medicine are not eligible. The Co-pay Program is valid ONLY for patients with commercial (private or non-governmental) insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medicine. Please visit the Co-pay Program website for the full list of Terms and Conditions.Īpply for the Genentech Oncology Co-pay Assistance Program Genentech reserves the right to rescind, revoke or amend the Program without notice at any time.Īdditional terms and conditions apply. Patients with health plans that redirect Genentech Program assistance intended for patient out-of-pocket costs may be subject to alternate Program benefit structures. The Program is not intended for third parties who reduce the amount available to the patient or take a portion for their own purposes. Only the patient using the Program may receive the funds made available through the Program. No party may seek reimbursement for all or any part of the benefit received through the Program. Territories, is void where prohibited by law and shall follow state restrictions in relation to AB-rated generic equivalents (e.g., MA, CA) where applicable. ![]() The Program is only valid in the United States and U.S. The Program benefit amount cannot exceed the patient’s out-of-pocket expenses for the cost associated with the Genentech medicine.Īll participants are responsible for reporting the receipt of all Program benefits as required by any insurer or by law. Patients using Medicare, Medicaid or any other federal or state government program (collectively, “Government Programs”) to pay for their Genentech medicine are not eligible. This includes, but is not limited to, Medicare, Medicaid and TRICARE
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |